Kurs & Likviditet
Kalender
2024-10-18 | Kvartalsrapport 2024-Q3 |
2024-07-18 | Kvartalsrapport 2024-Q2 |
2024-04-23 | Ordinarie utdelning GETI B 4.40 SEK |
2024-04-22 | Årsstämma 2024 |
2024-04-22 | Kvartalsrapport 2024-Q1 |
2024-02-01 | Bokslutskommuniké 2023 |
2023-10-23 | Kvartalsrapport 2023-Q3 |
2023-07-18 | Kvartalsrapport 2023-Q2 |
2023-04-27 | Ordinarie utdelning GETI B 4.25 SEK |
2023-04-26 | Årsstämma 2023 |
2023-04-26 | Kvartalsrapport 2023-Q1 |
2023-02-01 | Bokslutskommuniké 2022 |
2022-10-19 | Kvartalsrapport 2022-Q3 |
2022-07-19 | Kvartalsrapport 2022-Q2 |
2022-04-27 | Ordinarie utdelning GETI B 4.00 SEK |
2022-04-26 | Kvartalsrapport 2022-Q1 |
2022-04-26 | Årsstämma 2022 |
2022-01-28 | Bokslutskommuniké 2021 |
2021-10-20 | Kvartalsrapport 2021-Q3 |
2021-07-16 | Kvartalsrapport 2021-Q2 |
2021-04-21 | Ordinarie utdelning GETI B 3.00 SEK |
2021-04-20 | Kvartalsrapport 2021-Q1 |
2021-04-20 | Årsstämma 2021 |
2021-01-28 | Bokslutskommuniké 2020 |
2020-10-16 | Kvartalsrapport 2020-Q3 |
2020-07-16 | Kvartalsrapport 2020-Q2 |
2020-06-29 | Ordinarie utdelning GETI B 1.50 SEK |
2020-06-26 | Årsstämma 2020 |
2020-04-22 | Kvartalsrapport 2020-Q1 |
2020-01-30 | Bokslutskommuniké 2019 |
2019-10-18 | Kvartalsrapport 2019-Q3 |
2019-07-17 | Kvartalsrapport 2019-Q2 |
2019-04-24 | Ordinarie utdelning GETI B 1.00 SEK |
2019-04-23 | Årsstämma 2019 |
2019-04-23 | Kvartalsrapport 2019-Q1 |
2019-01-30 | Bokslutskommuniké 2018 |
2018-10-18 | Kvartalsrapport 2018-Q3 |
2018-07-17 | Kvartalsrapport 2018-Q2 |
2018-04-27 | Ordinarie utdelning GETI B 1.50 SEK |
2018-04-26 | Årsstämma 2018 |
2018-04-26 | Kvartalsrapport 2018-Q1 |
2018-01-29 | Bokslutskommuniké 2017 |
2017-10-18 | Kvartalsrapport 2017-Q3 |
2017-07-17 | Kvartalsrapport 2017-Q2 |
2017-04-25 | Kvartalsrapport 2017-Q1 |
2017-03-30 | Ordinarie utdelning GETI B 2.00 SEK |
2017-03-29 | Årsstämma 2017 |
2017-01-26 | Bokslutskommuniké 2016 |
2016-10-18 | Kvartalsrapport 2016-Q3 |
2016-07-14 | Kvartalsrapport 2016-Q2 |
2016-04-22 | Kvartalsrapport 2016-Q1 |
2016-03-31 | Ordinarie utdelning |
2016-03-30 | Årsstämma 2016 |
2016-01-28 | Bokslutskommuniké 2015 |
2015-10-15 | Kvartalsrapport 2015-Q3 |
2015-09-02 | Extra Bolagsstämma 2015 |
2015-07-15 | Kvartalsrapport 2015-Q2 |
2015-04-20 | Kvartalsrapport 2015-Q1 |
2015-03-26 | Ordinarie utdelning GETI B 2.80 SEK |
2015-03-25 | Årsstämma 2015 |
2015-01-28 | Bokslutskommuniké 2014 |
2014-10-16 | Kvartalsrapport 2014-Q3 |
2014-10-16 | Analytiker möte 2014 |
2014-07-15 | Kvartalsrapport 2014-Q2 |
2014-04-16 | Kvartalsrapport 2014-Q1 |
2014-03-21 | Ordinarie utdelning GETI B 4.15 SEK |
2014-03-20 | Årsstämma 2014 |
2014-01-28 | Bokslutskommuniké 2013 |
2013-10-15 | Analytiker möte 2013 |
2013-10-15 | 15-7 2013 |
2013-10-15 | Kvartalsrapport 2013-Q3 |
2013-07-11 | Kvartalsrapport 2013-Q2 |
2013-04-17 | Kvartalsrapport 2013-Q1 |
2013-03-22 | Ordinarie utdelning GETI B 4.15 SEK |
2013-03-21 | Årsstämma 2013 |
2013-02-08 | Kapitalmarknadsdag 2013 |
2013-01-25 | Bokslutskommuniké 2012 |
2012-10-17 | Analytiker möte 2012 |
2012-10-17 | Kvartalsrapport 2012-Q3 |
2012-07-11 | Kvartalsrapport 2012-Q2 |
2012-04-19 | Kvartalsrapport 2012-Q1 |
2012-03-29 | Ordinarie utdelning GETI B 3.75 SEK |
2012-03-28 | Årsstämma 2012 |
2012-01-26 | Bokslutskommuniké 2011 |
2011-10-20 | Kvartalsrapport 2011-Q3 |
2011-07-11 | Kvartalsrapport 2011-Q2 |
2011-04-28 | Ordinarie utdelning GETI B 3.25 SEK |
2011-04-27 | Kvartalsrapport 2011-Q1 |
2011-04-27 | Årsstämma 2011 |
2011-01-28 | Kapitalmarknadsdag 2011 |
2011-01-26 | Bokslutskommuniké 2010 |
2010-10-19 | Kvartalsrapport 2010-Q3 |
2010-04-23 | Ordinarie utdelning GETI B 2.75 SEK |
2010-04-22 | Ordinarie utdelning GETI B 2.75 SEK |
2010-04-21 | Årsstämma 2010 |
2010-04-21 | Kvartalsrapport 2010-Q1 |
2010-01-26 | Bokslutskommuniké 2009 |
2009-07-13 | Kvartalsrapport 2009-Q2 |
2009-05-06 | Kvartalsrapport 2009-Q3 |
2009-04-22 | Ordinarie utdelning GETI B 2.40 SEK |
2009-04-21 | Årsstämma 1 |
2009-04-21 | Kvartalsrapport 2009-Q1 |
2008-04-18 | Ordinarie utdelning GETI B 2.40 SEK |
2007-04-20 | Ordinarie utdelning GETI B 2.20 SEK |
2006-04-21 | Ordinarie utdelning GETI B 2.00 SEK |
2005-04-20 | Ordinarie utdelning GETI B 1.65 SEK |
2004-04-22 | Ordinarie utdelning GETI B 1.35 SEK |
2003-11-25 | Split GETI B 1:4 |
2003-04-24 | Ordinarie utdelning GETI B 4.25 SEK |
2002-04-19 | Ordinarie utdelning GETI B 3.75 SEK |
2001-04-24 | Ordinarie utdelning GETI B 3.50 SEK |
2000-04-28 | Ordinarie utdelning GETI B 3.50 SEK |
1999-04-22 | Ordinarie utdelning GETI B 3.25 SEK |
1998-04-24 | Ordinarie utdelning GETI B 2.75 SEK |
1997-04-30 | Ordinarie utdelning GETI B 2.50 SEK |
1996-04-19 | Ordinarie utdelning GETI B 6.00 SEK |
Beskrivning
Land | Sverige |
---|---|
Lista | Large Cap Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
Joanna Engelke has been appointed new Executive Vice President Quality Compliance, Regulatory & Medical Affairs and member of the Getinge Executive Team. She takes up the position on October 6, 2022.
Joanna Engelke most recently held the position as Head of New Ventures and Chief Quality Officer for JUUL Labs. Prior to JUUL Labs, she held leading positions as Senior Vice President Global Quality & Regulatory Affairs at Boston Scientific Corporation, Managing Director at Holloran Consulting Group and Portfolio CEO, Biospecific at PureTech Ventures among others. Joanna brings broad and solid experience from areas of regulatory healthcare in international companies.
Joanna will be a member of the Getinge Executive Team and report to Mattias Perjos, President & CEO. She takes up the position on October 6, 2022 replacing Lena Hagman, current EVP Quality Compliance, Regulatory & Medical Affairs who, as earlier communicated, has decided to leave the company.
To secure a smooth transition of handing over the overall quality responsibilities and plans, Lena Hagman will continue to support Getinge to the extent needed for a period of time.
Media contact:
Anna Appelqvist, Vice President Corporate Communications
Phone: +46 (0)10 335 5906
E-mail: anna.appelqvist@getinge.com
About Getinge
With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions that aim to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs over 10,000 people worldwide and the products are sold in more than 135 countries.